KATHERINE SAXTON BROWN, MD
Medical Practice at Potrero Ave, San Francisco, CA
License number
California 141065
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
1001 Potrero Ave, San Francisco, CA 94110
Phone
(415) 476-5192
(415) 476-1811 (Fax)
(415) 476-1811 (Fax)
Professional information
Mph - Program Manager At City Of Berkeley/Dance Instructor - Oakland And Berkeley
Position:
Community Health Advocate at Women's Cancer Resource Center, Dance Instructor at YWCA of Berkeley, Program Manager - Community and Neighborhood Health Programs and Services Unit at City of Berkeley
Location:
San Francisco Bay Area
Industry:
Health, Wellness and Fitness
Work:
Women's Cancer Resource Center
- Oakland, CA since 2006
-
Community Health Advocate
YWCA of Berkeley
- Berkeley, CA since Jun 2004
-
Dance Instructor
City of Berkeley
- Berkeley, CA since Aug 2000
-
Program Manager - Community and Neighborhood Health Programs and Services Unit
Dance-A-Vision Entertainment
Sep 2004 - Apr 2011
-
Dance Instructor
City of Berkeley
- Berkeley, CA Aug 2000 - Mar 2007
-
Project Coordinator - Tobacco Prevention.
Education:
San Francisco State University 2003 - 2006
MPH, Public Health MTPCCR 2004 - 2004
University of California, Berkeley 1996 - 2001
B.A., Interdisciplinary Studies Field Major
MPH, Public Health MTPCCR 2004 - 2004
University of California, Berkeley 1996 - 2001
B.A., Interdisciplinary Studies Field Major
Accounts Payable Manager At Waste Management
Location:
San Francisco Bay Area
Industry:
Environmental Services
Work:
Waste Management
Jan 2004 - Apr 2010
-
Accounts Payable Manager
AT&T
Jan 1995 - Dec 2000
-
Supervising Manager - Finance
Education:
Holy Names University
BS, Business Administration
BS, Business Administration
Dentist At Self
Position:
Dentist at Self
Location:
San Francisco Bay Area
Industry:
Medical Practice
Work:
Self
-
Dentist
Katherine Brown, DDS
2009 - 2010
-
Dr.
Modulators Of Rabggt And Methods Of Use Thereof
US Patent:
2004014, Jul 22, 2004
Filed:
Aug 7, 2003
Appl. No.:
10/638225
Inventors:
Veeraswamy Manne - Philadelphia PA, US
Mark Lynch - Madison CT, US
Petra Ross-MacDonald - Pennington NJ, US
Terry Stouch - West Windsor NJ, US
Naomi Laing - Stoneham MA, US
Pamela Carroll - Princeton NJ, US
Kevin Fitzgerald - Lambertville NJ, US
Louis Lombardo - Belle Mead NJ, US
Michael Costa - San Francisco CA, US
Mark Maxwell - San Francisco CA, US
Rachel Kindt - San Carlos CA, US
Mark Lackner - Brisbane CA, US
Tak Hung - Foster City CA, US
Carol O'Brian - Castro Valley CA, US
Hai Zhang - El Sobrante CA, US
Katherine Brown - San Francisco CA, US
Jae Lee - Cupertino CA, US
Mark Lynch - Madison CT, US
Petra Ross-MacDonald - Pennington NJ, US
Terry Stouch - West Windsor NJ, US
Naomi Laing - Stoneham MA, US
Pamela Carroll - Princeton NJ, US
Kevin Fitzgerald - Lambertville NJ, US
Louis Lombardo - Belle Mead NJ, US
Michael Costa - San Francisco CA, US
Mark Maxwell - San Francisco CA, US
Rachel Kindt - San Carlos CA, US
Mark Lackner - Brisbane CA, US
Tak Hung - Foster City CA, US
Carol O'Brian - Castro Valley CA, US
Hai Zhang - El Sobrante CA, US
Katherine Brown - San Francisco CA, US
Jae Lee - Cupertino CA, US
International Classification:
A61K048/00, G01N033/574, A61K031/5513, A61K031/47
US Classification:
514/044000, 514/221000, 514/310000, 435/007230
Abstract:
The present invention provides methods for inducing apoptosis in a cell, the methods generally involving contacting the cell with an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for treating a disorder related to unwanted cell proliferation in an individual, the methods generally involving administering to the individual an agent that reduces the level and/or activity of RabGGT. The present invention further provides methods for reducing apoptosis in a cell, the methods generally involving increasing the level and/or activity of RabGGT in the cell. The present invention further provides methods for treating disorders associated with excessive apoptosis. The present invention further provides methods for identifying a cell that is amenable to treatment with the methods of the present invention. The present invention further provides methods for modulating a binding event between RabGGT and a RabGGT interacting protein. The present invention further provides a 3-dimensional structure of RabGGT, and methods of use of the structure to identify compounds that modulate RabGGT activity.
Katherine Brown
Location:
San Francisco Bay Area
Industry:
Accounting